Skip to main contentShah's Gastro, Cancer & Robotic Surgery Centre · Ahmedabad & Gandhinagar
Esophageal cancer treatment in Ahmedabad · Gota OPD, Ahmedabad · Apollo Hospital, Bhat, Gandhinagar
Food that sticks on the way down is first a question for the endoscope, not for the operating theatre. At Shah’s Gastro, Cancer & Robotic Surgery Centre the pathway runs in a fixed order: an endoscopy with biopsies tells whether the narrowing is cancer or something benign; staging scans then show how far a cancer has gone; and only then is a treatment chosen from a ladder that runs from removal through the endoscope, through chemotherapy and radiation, to an operation — or, for some patients, no operation at all.
The same gastro team that performs the endoscopy, reads the staging, and sits on the tumour board also performs the operation when one is needed — so the decision about which rung of the ladder suits you is not made by someone who offers only one rung.
Shah’s Gastro, Cancer & Robotic Surgery Centre. Trained in super-specialty surgical gastroenterology programmes, qualified twice over in the specialty, with 18 years of experience in GI and cancer surgery. Upper GI endoscopy, staging, the tumour board, keyhole and open surgery of the food pipe, and long-term follow-up all sit within one practice.
Dr Harsh Shah
MS, MCh (Surgical Gastroenterology), DrNB (Surgical Gastroenterology)
Registered with Gujarat Medical Council, Reg. No. G-38738
Food Pipe Cancer Surgeon · Apollo Hospital, Bhat, Gandhinagar · Gota OPD, Ahmedabad
Google rating 4.89 from 216 reviews at the Gota clinic, and 4.94 from 17 reviews at Apollo, Bhat.
Most people reach this page after one of three moments: food has begun to stick in the chest, a family doctor has asked for an endoscopy, or an endoscopy report already says “growth” or “mass”. Each of those people needs the same next step — the right test in the right order — before anyone talks about treatment. Skipping ahead is how patients end up with the wrong operation, or an operation they never needed.
The pathway starts with an upper GI endoscopy and several biopsies, because only tissue tells cancer from a benign narrowing. Once cancer is confirmed, CT and PET-CT look for spread, endoscopic ultrasound is added only when it changes the decision, and heart and lung tests come before any plan that involves the chest.
| Step | Test | The question it answers |
|---|---|---|
| First | Upper GI endoscopy with several biopsies, photographs and measured distances; special dye or light to map the edges | Is this cancer, and exactly where does it start and stop? |
| Second | Contrast CT of the chest, abdomen and pelvis | Has it spread to the liver, lungs or lymph nodes? |
| Third | PET-CT, for anyone in whom treatment to remove the cancer completely is being considered | Is there hidden spread that would make a major operation pointless? |
| Where it changes the decision | Endoscopic ultrasound | Is an early cancer confined to the lining, or deeper? Is a nearby node involved? |
| Squamous cancer of the upper and middle food pipe | Bronchoscopy, and an ENT examination of the throat | Is the windpipe involved? Is there a second cancer in the head and neck? |
| Cancer at the junction with the stomach | Staging laparoscopy | Are there deposits on the lining of the abdomen too small for any scan? |
| Before any chest operation | ECG, echocardiogram, lung function tests with gas transfer, blood tests and nutrition screen | Can this body safely take the treatment being planned? |
Two points save patients time and money. First, a surgeon’s own endoscopy is often worth repeating even after an outside one, because the surgeon who has to define the margin benefits from seeing the upper and lower edges himself. Second, blood “tumour markers” do not decide anything in esophageal cancer; a raised or normal value neither confirms nor excludes the disease, and treatment is never chosen on a marker.
Difficulty swallowing has several benign causes — long-standing reflux with narrowing, achalasia, a benign muscle lump and others — and some of them can look like cancer on a scan. The biopsy, read together with the endoscopic picture, is what separates them; each benign condition then follows its own, very different treatment.
| What the patient notices | Points towards | What settles it |
|---|---|---|
| Solid food sticks first, liquids later, with weight loss | A mechanical narrowing — cancer until proven otherwise | Endoscopy with multiple biopsies |
| Solids and liquids are both difficult from the start, with undigested food coming back | A motility disorder such as achalasia | Endoscopy first to exclude a hidden cancer at the junction, then manometry |
| Years of acidity, now with new difficulty swallowing | Reflux narrowing, Barrett’s change, or a cancer arising in Barrett’s | Urgent endoscopy with biopsies of every irregular area |
| A smooth bulge under normal lining | A lump in the wall, such as a leiomyoma or GIST | Endoscopic ultrasound; managed on a separate pathway |
| Hoarse voice or cough on swallowing | A later sign — possible involvement of the nerve to the voice box or the windpipe | Same-day assessment by the consultant surgeon |
A point that matters to families: an “achalasia” label given without an endoscopy first is not a safe label. Rapid weight loss over a short history in an older person is treated as a possible cancer at the junction until the endoscopy and biopsies say otherwise. Barrett’s change with abnormal cells is treated within cancer care, because it can progress.
Esophageal cancer is treated by stage and by type. The earliest cancers are removed through the endoscope; slightly deeper early cancers need an operation straight away; locally advanced cancers receive chemotherapy or chemoradiation before surgery; some are treated with chemoradiation alone; and cancer that has spread is treated with drugs and measures that keep swallowing open.
| Rung | Who it suits | What it involves |
|---|---|---|
| Endoscopic removal (EMR or ESD) | The earliest cancer, confined to the inner lining | The cancer is lifted out through the endoscope; the food pipe is kept. In Barrett’s, any remaining abnormal lining may be ablated |
| Operation first | An early cancer that has gone a little deeper, or showed unfavourable features after endoscopic removal | Esophagectomy with removal of lymph nodes, without treatment beforehand |
| Chemoradiation, then operation | Locally advanced squamous cell cancer in a fit patient | A course of chemotherapy with radiation, a reassessment, then esophagectomy some weeks later |
| Chemotherapy before and after the operation | Locally advanced adenocarcinoma, including the junction with the stomach | Cycles of combination chemotherapy, the operation, then the remaining cycles |
| Chemoradiation alone | Squamous cancer high in the neck, cancer grown into a vital structure, or a patient unfit for or declining surgery | Definitive chemoradiation, then close surveillance with surgery held in reserve |
| Medicines for spread disease, and relief of swallowing | Cancer in distant organs | Chemotherapy with immunotherapy chosen by biomarkers; a stent or radiotherapy for swallowing; early palliative care and nutrition support |
Many patients with esophageal cancer are better served without an esophagectomy: the earliest cancers are removed through the endoscope, squamous cancers high in the neck are treated with chemoradiation, and cancer that has spread is treated with medicines. Saying so plainly at the first visit is part of a complete service.
The opposite mistake also happens. An early cancer removed through the endoscope is examined under the microscope, and if it turns out deeper than expected, has spread into small vessels, is poorly formed, or reaches the cut edge, simply watching it is under-treatment. That patient moves up the ladder to an operation, and the decision is made by the tumour board on the pathology report.
A second group raises a decision of its own. After chemoradiation, some patients have no visible cancer left. Whether to operate anyway or to watch closely with endoscopies and scans, operating only if it returns, is an emerging question rather than a settled standard — it is discussed only at the tumour board, and only where an operation can still be done later if needed.
The biopsy names the type of cancer, and the type sets the treatment before surgery. Squamous cell cancer usually receives chemotherapy with radiation first; adenocarcinoma usually receives a chemotherapy course split around the operation. Giving one pathway’s treatment to the other patient is an avoidable error.
Treatment before the operation has two jobs: to shrink the tumour so that it can be removed completely, and to treat cancer cells that no scan can see. For adenocarcinoma, if a patient is not suited to the chemotherapy course, chemoradiation is an accepted alternative. For a squamous cancer, chemoradiation can also be the whole treatment when an operation is not advisable.
While this treatment runs, swallowing may get worse before it gets better. If eating becomes nearly impossible and an operation is planned, a feeding tube into the small bowel is preferred to a stent across the tumour, because a stent can complicate the operation. A dietitian sees every patient who has lost a noticeable amount of weight, is eating far less than needed, or has low protein in the blood. The rule is simple: nutrition is never allowed to be the reason treatment stops.
An esophagectomy removes the cancerous part of the food pipe with its lymph nodes and rebuilds the passage, usually by shaping the stomach into a tube and drawing it up. It is offered when staging shows the cancer can be removed completely and heart and lung tests show the body can carry the operation.
Where the new join is made depends on where the tumour sits: in the chest for a cancer of the lower food pipe or the junction, and in the neck for a cancer higher up, or when the upper margin is a concern. Keyhole and robot-assisted approaches are used where the tumour and tissues allow, because they reduce lung complications compared with a fully open operation; a bulky tumour or tissues stiffened by chemoradiation may need open surgery. A feeding tube into the small bowel is placed at the operation when it is likely to be needed.
Preparation is part of treatment. Stopping smoking and alcohol well ahead, walking daily, breathing exercises with a spirometer, correcting anaemia and building protein all reduce the lung problems that are the commonest difficulty after this operation. A dental check removes any hidden source of infection.
For cancer that has reached distant organs, treatment is chemotherapy combined with immunotherapy or a targeted drug, chosen by tests on the tumour — HER2, PD-L1 and mismatch-repair status — whose results should be back before the first cycle starts. Swallowing is protected with a stent or radiotherapy.
These biomarker tests change which medicine is offered first, so they are requested at the first visit rather than after treatment has begun. Some of the newer medicines carry cost and access limits in India; these are raised early and discussed openly, including patient-access programmes. Palliative care and nutrition support start at diagnosis for every patient with spread disease — not at the end — because comfort, weight and the ability to swallow decide how well people live during treatment.
Each rung carries its own risks. An esophagectomy carries real risks, including the risk of death, and Dr Harsh Shah names each one at the consent discussion with figures adjusted to your age, fitness and prior treatment. Risk rises with poor lung function, other illnesses and treatment given before surgery.
After an esophagectomy: a leak at the join; chest infection and other lung problems; an irregular heartbeat; a hoarse voice from strain on the nerve to the voice box, which usually recovers; a milky lymph leak into the chest; poor blood supply to the new food pipe; bleeding, wound infection and clots. Longer term: narrowing at the join that may need stretching through the endoscope, acid or bile coming back up, and feeling unwell after a large meal. Endoscopic removal and chemoradiation carry their own, different risks, which are explained before each starts.
Follow-up depends on the rung you were treated on. After endoscopic removal, repeat endoscopies are the core; after chemoradiation alone, endoscopy and CT are close and frequent so that a recurrence can still be operated on; after an esophagectomy, visits and CT scans continue for many years, most often in the early years.
At the first follow-up visit after an operation, the pathology report is explained in person and the next step is set: no further treatment if no cancer was left, immunotherapy for about a year if cancer remained after chemoradiation, or completion of the chemotherapy course. Lifelong, follow-up covers weight, swallowing, vitamin and iron levels, reflux precautions and the small, frequent meals that suit a rebuilt food pipe.
Dr Harsh Shah explains the tests on this page — endoscopy, biopsy, CT and PET-CT — and what each one adds.
A patient describes the operation and recovery after an esophagectomy by Dr Harsh Shah, recorded and shared with written consent.
The cost of esophageal cancer treatment depends on which rung you need — an endoscopic removal, a course of chemoradiation, an esophagectomy, or medicines for spread disease — and on the room category and length of stay. A written estimate is given before treatment starts and its contents are explained.
Apollo Hospital, Bhat, works with the major insurers and cashless schemes, and the office handles pre-authorisation directly; if a stay runs longer than estimated, an enhancement request is raised at the time rather than at discharge. Immunotherapy and some targeted medicines carry their own cost, and access programmes are discussed openly when they are advised.
Bring: every endoscopy report with photographs, biopsy and pathology reports, CT and PET-CT images on a disc or drive, previous treatment summaries, a list of medicines, the insurance card and identification, and one family member as the point of contact.
★★★★★
“Met with Dr. Harsh Shah for the consultation of one of my relative. Dr. Harsh Shah is an exceptional surgical oncologist in Ahmedabad. His expertise in treating complex GI cancers like liver, pancreas, and colon cancers is truly remarkable. He explains everything clearly and gives patients full confidence in their treatment. Highly recommended for anyone looking for a skilled and compassionate cancer specialist. — Nagesh Patidar, Google review, Gota clinic listing”
★★★★★
“Dr. Harsh Shah is an excellent doctor who handled our case with great diligence and care. He listens attentively and addresses every concern with utmost patience. He's very humble and answers all of your questions in detail which is very assuring. I would highly recommend Dr. Harsh Shah for consultation and treatment. — Srinath Vasudevan, Google review, Gota clinic listing”
★★★★★
“Excellent service, very polite, very well explained the treatment plan and follow up after surgery. I am truly grateful to him for the treatment. — Amar Singh, Google review, Gota clinic listing”
Real Google reviews from Dr Harsh Shah’s listings, reproduced exactly as written.
Not necessarily. Reflux narrowing, achalasia and benign lumps in the wall can all narrow the food pipe. Only biopsies taken at endoscopy, read with the endoscopic picture, settle whether it is cancer.
An upper GI endoscopy with several biopsies comes first. CT and PET-CT follow once cancer is confirmed, and endoscopic ultrasound, bronchoscopy or staging laparoscopy are added only where they change the decision.
Yes, for several groups: the earliest cancers removed through the endoscope, squamous cancers high in the neck treated with chemoradiation, patients unfit for surgery, and cancer that has spread, which is treated with medicines.
For locally advanced cancer it shrinks the tumour and treats cells no scan can see, which makes a complete removal more likely. The cancer type decides whether it is chemoradiation or a chemotherapy course.
No. Tumour markers do not decide anything in esophageal cancer. Diagnosis rests on biopsy, and staging on scans.
If an operation is planned, a feeding tube into the small bowel is usually preferred, because a stent can complicate surgery. For patients who will not have an operation, a stent or radiotherapy is a good way to keep swallowing open.
Shah’s Gastro, Cancer & Robotic Surgery Centre — Gota, Ahmedabad
Consultations, endoscopy planning, review of scans, follow-up and surveillance.
Google: Dr Harsh Shah · 4.89 from 216 reviews
Directions to the Gota clinic · +91-63555-64601
Apollo Hospital — Bhat, Gandhinagar
Apollo Hospital International Limited, Plot No. 1 A, GIDC Bhat Industrial Estate, Bhat, Gandhinagar.
Google: Dr Harsh Shah – Robotic GI Surgeon · 4.94 from 17 reviews
Directions to Apollo, Bhat · WhatsApp +91-63555-64601
Patients come to Ahmedabad for esophageal cancer treatment from across Gujarat — Gandhinagar, Mehsana, Banaskantha, Nadiad, Anand, Bhavnagar, Rajkot, Jamnagar and Kutch — and from southern Rajasthan and western Madhya Pradesh.
Have an endoscopy or biopsy report already? The endoscopy report and photographs, the biopsy report and any CT or PET-CT images can be sent ahead of your appointment, so the consultation starts with them already read. Treatment is decided at the consultation, after examination. Call +91-63555-64601 · Send the reports ahead on WhatsApp
Swasth Parivar: twice a month, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.
